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Tissue Antigens Are Not Sequestered but Are Expressed in
Thymus.
 
For many years, it has been hypothesized that a
major factor in organ-specific autoimmunity is a lack of
central tolerance to self-antigens that are sequestered behind
anatomical barriers in organs such as the eye, testis, and
brain. However, numerous studies published in the last few
years argue strongly that this concept of sequestration of tissue-
specific antigens in such immune-privileged organs should
be revised. Many tissue-specific antigens are now known to
be expressed in the thymus (for review see 1) primarily in
medullary thymic epithelial cells (mTECs) (2), which appear
to be a specialized subset of cells that may mediate deletion
of self-reactive T cells and/or the induction of regulatory T
 
cells (Tregs). Genetic analysis of a group of human autoim-
mune diseases known as autoimmune polyendocrinopathy-
candidiasis-ectodermaldystrophy (APECED) has shown
that the expression of tissue antigens in mTECs may be
mediated by a transcription factor called AIRE (autoimmune
regulator). Both mice and humans deficient in AIRE develop
a polyglandular disorder characterized by autoimmunity
involving the parathyroid and/or adrenal glands (3). AIRE,
which is expressed predominantly in mTECs, has now
been demonstrated to act as a master regulator of the ex-
pression of many tissue-specific antigens, including antigens
that are targeted in APECED, such as salivary proteins 1
and 2 (4). How AIRE mediates transcription of all these
tissue-specific antigens in mTECs has not been elucidated.
It is important to note that although AIRE regulates thymic
expression of 
 
 
 
100–300 genes, AIRE deficiency results in
autoimmunity directed to a restricted set of antigens. It is
therefore tantalizing to speculate whether paralogs of AIRE
exist that control thymic expression of a distinct cohort of
tissue-specific antigens that are involved in other autoim-
mune diseases.
 
Thymic Expression of Tissue Antigens Shapes the Self-reactive
Repertoire.
 
The fact that tissue-specific antigens are expressed
in the thymus makes less tenable the hypothesis that autoim-
munity results from a failure to impose central tolerance on
the developing T cell. Recent studies in different animal
models of autoimmunity have shed some light on how tol-
erance is achieved and subverted in individuals where the
target antigen is expressed in the thymus. Here, we illustrate
three different scenarios that arise from these studies.
In the first scenario, self-antigen expressed in the thymus
deletes high affinity self-reactive T cells, whereas low affinity
T cells are seeded to the periphery. Evidence for this comes
from studies of the T cell repertoire specific for myelin basic
protein (MBP), which is a target antigen in experimental
autoimmune encephalomyelitis (EAE), an animal model of
multiple sclerosis. MBP-deficient, C3H (H-2
 
k
 
) mice immu-
nized with whole MBP, exhibit a strong T cell response to
MBP 79–87, whereas WT mice exhibit a response that is at
least 3 logs lower in avidity (5).
In the second scenario, self-reactive cells escape thymic
deletion because the isoform of the antigen expressed in the
thymus differs from that expressed in the target organ. This
is best illustrated by studies of the T cell repertoire specific
for myelin proteolipid protein (PLP), another target antigen in
EAE. The predominant form of PLP expressed in the thymus
is a splice variant, DM20, that lacks residues 116–150 of the
full-length protein (6,7). Thus, only cells that react with
epitopes within DM20 would be expected to undergo central
tolerance. Indeed, this has been shown to be the case in
studies of the T cell repertoire to PLP in WT versus PLP-
deficient C57BL/6 mice (7).
In the last scenario, thymically expressed self-antigens do
not mediate central tolerance due to inefficient antigen
presentation by MHC alleles present in the individual. This
mechanism has been proposed to explain the escape from
tolerance of MBP 1–11–reactive T cells. MBP 1–11, which
is expressed in the thymus (8), has been shown to bind
 
weakly to I-A
 
u
 
 (9) and to form unstable peptide–MHC
complexes (10), resulting in the escape of self-reactive cells
from thymus. In addition, MHC instability and poor peptide
binding may also underlie the susceptibility of nonobese
diabetic (NOD) mice to autoimmunity. In the NOD
strain, homozygosity for the I-A
 
g7
 
 allele is strongly associated
with susceptibility to type-1 diabetes. This MHC molecule
has been shown to be structurally unstable and to bind disease-
related self-peptides poorly (11–13). Collectively, these
examples demonstrate that the expression of self-antigen in
thymus shapes the self-reactive repertoire, but in some
cases deletion may not be complete or may not occur at all
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due to the limited affinity of the MHC molecule for the
self-antigen or due to expression of a splice variant or iso-
form of the self-antigen.
 
How Much Antigen Must Be Expressed in the Thymus?
 
All of the mechanisms illustrated above involve expression
of self-antigen in the thymus. What about the cases where
thymic expression of the self-antigen has not been detected
by standard techniques? In this issue, Avichezer et al. ex-
amine the effects of loss of expression of interphotoreceptor
binding protein (IRBP), a target antigen in experimental
autoimmune uveitis (EAU), on the T cell repertoire (14).
Previous examination using RT-PCR and immunoblot-
ting techniques had shown that IRBP expression in the
thymus correlates with disease susceptibility and resistance
to EAU, with resistant strains of mice exhibiting detectable
IRBP and susceptible strains lacking expression (15). Sur-
prisingly, Avichezer et al. demonstrate that IRBP defi-
ciency in the susceptible strain B10.RIII, which had been
shown previously to lack detectable IRBP expression in
the thymus, has dramatic effects on the T cell repertoire to
IRBP. The authors find that the T cell response to the im-
munodominant epitope of IRBP is augmented and that ad-
ditional T cell epitopes are uncovered in IRBP-deficient
mice. This prompted the authors to use ultrasensitive im-
munohistochemistry coupled with RT-PCR analysis of
microdissected tissue to demonstrate that IRBP is in fact
expressed in the thymus of B10.RIII mice. Interestingly,
IRBP expression is seen in very small clusters of cells lo-
cated in the medulla and cortico–medullary junction (14).
Although the authors do not formally identify the cell type
that expresses IRBP, it is possible that they are mTECs.
These results suggest that a seemingly miniscule amount
of self-antigen expression can have a dramatic effect on
self-tolerance and that central tolerance should not be ruled
out in cases where attempts to detect expression of self-
antigen in the thymus by conventional techniques have
yielded negative results. This raises the question of how do
all of the millions of self-reactive T cells generated in the
thymic cortex come in contact with the few mTECs ex-
pressing self-antigen? It is possible that mTECs produce
factors that specifically attract developing thymocytes to
them, thereby increasing the likelihood that cells bearing
deleterious self-reactive receptors will come in contact
with self-antigen and undergo tolerance.
That ectopic thymic expression of tissue-specific anti-
gens is not absolutely required for shaping the self-reactive
T cell repertoire is illustrated in another model of MBP-
induced EAE. In MBP-deficient mice on the H-2
 
u
 
 back-
ground, the immunodominant epitope is MBP 121–150. T
cells reactive to this epitope are virtually undetectable in
WT mice, suggesting that they undergo central tolerance
(10). Given that MBP 121–150 is not synthesized in the
thymus (8, 16, 17), how could central tolerance be elicited?
It has now been shown that BM-derived antigen-present-
ing cells acquire MBP 121–150 exogenously, carry it into
the thymus, and mediate central tolerance (18). Therefore,
lack of thymic expression of self-antigen may not always
preclude deletion of self-reactive T cells. Although exoge-
 
nous self-antigen that is carried to the thymus can mediate
central tolerance by deletion in thymus, it is not known if
it also has a role in the generation of Tregs or if the genera-
tion of Tregs is a unique property of self-antigen synthe-
sized in the thymus by mTECs.
 
Thymus Is the Nursery for the Generation of Regulatory T
Cells.
 
Although for many years the major role of the thy-
mus was considered to be the deletion of self-reactive cells,
evidence existed in the literature that the thymus is also the
seat of the generation of regulatory T cells (19–21). It had
been shown previously that the thymus was very efficient in
generating regulatory T cells (20) and that mice thymecto-
mized 3 d after birth develop multiorgan autoimmune dis-
eases (22). In this regard, Avichezer et al. show that depletion
of CD25
 
 
 
 Tregs increases susceptibility to EAU and that
these regulatory cells are thymus derived (14). Although the
authors clearly show that Tregs have a role in IRBP-induced
EAU, they do not directly address whether they are depen-
dent on IRBP for their generation or are specific for IRBP.
The small amount of IRBP present in the thymus appears to
be sufficient to eliminate some IRBP specificities, but does it
have a role in generating Tregs? Assuming it does, would
even lower expression of IRBP render deletion of the T cell
repertoire to IRBP ineffective but still result in the genera-
tion of the Tregs? In other words, is there an amount of self-
antigen expression that is sufficient for the generation of
Tregs but not sufficient for the deletion of self-reactive T cell
specificities or vice versa? Consistent with the idea that this is
a quantitative issue is the suggestion that the affinity of Tregs
teeters on the edge of the range of affinities that would be
expected to undergo negative selection in the thymus (23). If
this is the case, then why are these cells not deleted but sus-
tained and exported to the periphery? The solution to this
conundrum might lie in understanding the expression pat-
tern and function of the transcription factor Foxp3. Foxp3 is
up-regulated in Tregs and is involved in inhibiting many T
cell functions including the production of cytokines (24–26).
It is possible that self-reactive T cells that come in contact
with their cognate antigen in thymus avoid deletion by up-
regulation of Foxp3 and thus become Tregs. Other cells that
are not able to up-regulate expression of Foxp3 are purged
from the repertoire. Another possibility is that Tregs are a
different lineage of T cells that develop and mature by com-
ing in contact with self-antigens in the thymus; however,
there is little support for this proposition.
What emerges is an interesting picture of how the ex-
pression of tissue-specific antigens in the thymus can im-
pose tolerance by different means: deletion of self-reactive
T cells and induction of regulatory T cells. Two different
transcription factors, AIRE and Foxp3, have been shown
to play a crucial role in imposing this tolerance, one
(AIRE) regulates the expression of tissue antigens in the
thymus and the other (Foxp3) plays a crucial role in the in-
duction of anergy and generation of Tregs. Natural muta-
tions of both of these transcription factors in humans and
mice induce devastating multiorgan autoimmune diseases,
but the phenotype resulting from Foxp3 deficiency is far
more severe (3, 27). This raises the important question of 
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whether the principal function of the thymus is in generat-
ing Tregs and whether this function is more important than
its role in purging self-reactive T cells from the developing
repertoire. Additionally, the phenotype resulting from
Foxp3 deficiency is also more severe than that resulting
from depletion of CD4
 
 
 
CD25
 
 
 
 Tregs. This could suggest
that Foxp3 also plays a role in other mechanisms of central
tolerance or in generating regulatory T cells that are not
defined by the CD4
 
 
 
CD25
 
 
 
 phenotype.
Although AIRE and Foxp3 are important clues in the
quest to unravel the mechanisms of negative selection and
generation of Tregs in the thymus, our knowledge of these
processes is still in its infancy. The next breakthrough may
lie in answering the most burning question of all: what is
the antigen specificity of Tregs? Although induced by ex-
posure to self-antigen in the thymus, we may find that
Tregs are not specific but are broadly cross-reactive to mul-
tiple self-antigens and thus provide a protective shield by
inhibiting immune responses to self and preventing immu-
nopathology mediated by nonself.
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